Fisher Stewart
- SEC CIK
- 0001824863
No open-market purchases or sales filed in the past year.
Current role at each company
- CCCC C4 Therapeutics, Inc.Chief Scientific Officeras of Sep 17, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Fisher Stewart as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 5, 2021 (view filing) | Aug 3 | 2 days | Fisher StewartChief Scientific Officer | SSale | −17.1K | $45.01 | −$767.7K | −42.9%22.7K after | |
| Aug 2, 2021 (view filing) | Jul 29-Aug 2 | 4 days | Fisher StewartChief Scientific Officer | SSale | −68.3K | $45.00 | −$3.07M | −63.2%39.8K after | 2 lots |